Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Anesthesia Induction in Prostatectomy
NCT06093971Completed
- Sponsor
- Yonsei University
- Start
- Nov 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in Prostatic neoplasm (2 arms), sponsored by Yonsei University. Primary endpoints: Hypotension occurrence, Amount of hypotension and 2 more. Started Nov 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
Prostatic neoplasm
Beyond the preview
Go deeper on NCT06093971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06093971.